<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a <z:hpo ids='HP_0011010'>chronic</z:hpo> relapsing multisystem <z:hpo ids='HP_0002633'>vasculitis</z:hpo> with 49% of cases involving the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Recently there have been two reports of neuro-<z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease (NB) successfully treated with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNFalpha) monoclonal antibody infliximab </plain></SENT>
<SENT sid="2" pm="."><plain>We describe a patient with longstanding NB who was poorly responsive to <z:chebi fb="2" ids="2948">azathioprine</z:chebi>, cyclosporin, thalidomide and <z:chebi fb="0" ids="44185">methotrexate</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>She showed a remarkable response when treated with the recombinant human TNFalpha receptor protein, etanercept </plain></SENT>
<SENT sid="4" pm="."><plain>To the best of our knowledge this is the first report of NB successfully treated with etanercept </plain></SENT>
</text></document>